Sumitomo Chemical Company Pharma Rejects Gotham City Research Report

TOKYO, Aug 04 (Pulse News Wire) – Sumitomo Chemical Company,limited (4005.T) announced that its subsidiary, Sumitomo Pharma Kabushiki Kaisha, released a statement addressing a report published by Gotham City Research LLC on August 3, 2026. Details of the report can be found in the attached documents.

On August 3, 2026, Gotham City Research LLC published a report concerning Sumitomo Pharma Co., Ltd. (headquartered in Osaka, represented by President Kimura Toru). Sumitomo Pharma stated that the report reflects the author's independent views and assertions and does not represent the company’s stance. Sumitomo Pharma confirmed that it adheres to laws and applicable accounting standards in preparing and disclosing consolidated financial statements and financial statements (hereinafter referred to as “financial statements”).

The company undergoes audits conducted by certified public accountants based on the Financial Instruments and Exchange Act and the Companies Act, receiving unqualified opinions. As of now, the company has not verified any inaccuracies in the reported financial statements or inappropriate accounting treatments mentioned in the report. Therefore, there are currently no plans to revise the disclosed financial statements. Sumitomo Pharma reaffirmed its commitment to timely and appropriate information disclosure moving forward.